<DOC>
	<DOCNO>NCT00604955</DOCNO>
	<brief_summary>This modular Program first confirm safety efficacy Paromomycin IM Injection give expand population outpatient set experienced VL center subsequently evaluate effectiveness expand access model provide Paromomycin IM Injection progressively resource-constrained clinic Bihar , India .</brief_summary>
	<brief_title>Expand Access/Assess Safety Efficacy Paromomycin IM Injection Treatment Visceral Leishmaniasis</brief_title>
	<detailed_description>Safe , effective , affordable treatment visceral leishmaniasis ( VL ) widely available poor population rural India disease endemic urgently need . Resistance antimonials , historically first line treatment VL Bihar adjoin state , major problem . Other available treatment limit high cost , toxicity , contraindication certain population . Paromomycin IM Injection approve treatment VL August 2006 Drug Controller General India ( DCGI ) . The study design establish Phase 4 Access Program modular , stepwise fashion ( Modules 1 3 ) . The study first confirm safety efficacy Paromomycin IM Injection expand VL population treat outpatient experienced center ( Module 1 ) ; progressively extend network treatment facility , number reach trained staff , implementation requisite logistics system rural Bihar ( Modules 2 3 ) . An expanded network healthcare worker train supervised make preliminary diagnosis VL ; make appropriate referral confirm diagnosis VL ; treat Paromomycin IM Injection ; assess patient safety clinical response outpatient basis .</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis , Visceral</mesh_term>
	<mesh_term>Paromomycin</mesh_term>
	<criteria>Confirmed , newly diagnose relapsed visceral leishmaniasis HIV infection , tuberculosis Significant hematologic , renal liver dysfunction Malaria Those unable treated outpatient .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>visceral leishmaniasis</keyword>
	<keyword>kala-azar</keyword>
	<keyword>Bihar , India</keyword>
</DOC>